Literature DB >> 19812338

A reporter of local dendritic translocation shows plaque- related loss of neural system function in APP-transgenic mice.

Melanie Meyer-Luehmann1, Matthew Mielke, Tara L Spires-Jones, Will Stoothoff, Phill Jones, Brian J Bacskai, Bradley T Hyman.   

Abstract

Although neuronal communication is thought to be summated within local dendritic segments, no technique is currently available to monitor activity in vivo at this level of resolution. To overcome this challenge, we developed an optical reporter of neuronal activity using the coding sequence of Venus, flanked by short stretches of the 5'- and 3'-untranslated regions from calcium/calmodulin-dependent kinase IIalpha (CAMKIIalpha). This reporter takes advantage of the fact that CAMKIIalpha mRNA is transported to the dendrite and locally translated in an activity-dependent manner. Using adeno-associated virus, we used this reporter to study neuronal activity in adult mice. Exposure of the mice to an enriched environment led to enhancement of Venus expression in dendritic segments of somatosensory cortex, demonstrating in vivo that dendritic mRNA translocation and local translation occur in response to physiologically relevant stimuli. We then used this system to examine the impact of Alzheimer-related local amyloid-beta deposits on neural system function to test the hypothesis that plaques are toxic. In APPswe/PS1dE9 (APP/PS1) mice, neurons close to plaques, and dendritic segments close to plaques, both showed diminished fluorescent intensity and therefore neuronal activity. In contrast to wild-type mice, fluorescent intensity in neurons near plaques in transgenic mice did not increase after environmental enrichment. These data indicate that neuronal activity in dendritic segments and neurons in the vicinity of a plaque is decreased compared with wild-type mice, supporting the idea that plaques are a focal lesion leading to impaired neural system function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19812338      PMCID: PMC2789808          DOI: 10.1523/JNEUROSCI.1948-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  25 in total

1.  Two cis-acting elements in the 3' untranslated region of alpha-CaMKII regulate its dendritic targeting.

Authors:  Y Mori; K Imaizumi; T Katayama; T Yoneda; M Tohyama
Journal:  Nat Neurosci       Date:  2000-11       Impact factor: 24.884

2.  Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques.

Authors:  Edward A Stern; Brian J Bacskai; Gregory A Hickey; Frank J Attenello; Julianne A Lombardo; Bradley T Hyman
Journal:  J Neurosci       Date:  2004-05-12       Impact factor: 6.167

3.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

4.  A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications.

Authors:  Takeharu Nagai; Keiji Ibata; Eun Sun Park; Mie Kubota; Katsuhiko Mikoshiba; Atsushi Miyawaki
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

5.  Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption.

Authors:  R Le; L Cruz; B Urbanc; R B Knowles; K Hsiao-Ashe; K Duff; M C Irizarry; H E Stanley; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

6.  Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.

Authors:  William E Klunk; Brian J Bacskai; Chester A Mathis; Stephen T Kajdasz; Megan E McLellan; Matthew P Frosch; Manik L Debnath; Daniel P Holt; Yanming Wang; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2002-09       Impact factor: 3.685

7.  In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories.

Authors:  J D D'Amore; S T Kajdasz; M E McLellan; B J Bacskai; E A Stern; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2003-02       Impact factor: 3.685

8.  Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

Authors:  Brian J Bacskai; Stephen T Kajdasz; Megan E McLellan; Dora Games; Peter Seubert; Dale Schenk; Bradley T Hyman
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1.

Authors:  Joanna L Jankowsky; Hilda H Slunt; Victoria Gonzales; Nancy A Jenkins; Neal G Copeland; David R Borchelt
Journal:  Neurobiol Aging       Date:  2004-08       Impact factor: 4.673

10.  Amyloid suppresses induction of genes critical for memory consolidation in APP + PS1 transgenic mice.

Authors:  Chad A Dickey; Marcia N Gordon; Jerimiah E Mason; Nedda J Wilson; David M Diamond; John F Guzowski; Dave Morgan
Journal:  J Neurochem       Date:  2004-01       Impact factor: 5.372

View more
  31 in total

1.  Limited availability of ZBP1 restricts axonal mRNA localization and nerve regeneration capacity.

Authors:  Christopher J Donnelly; Dianna E Willis; Mei Xu; Chhavy Tep; Chunsu Jiang; Soonmoon Yoo; N Carolyn Schanen; Catherine B Kirn-Safran; Jan van Minnen; Arthur English; Sung Ok Yoon; Gary J Bassell; Jeffery L Twiss
Journal:  EMBO J       Date:  2011-09-30       Impact factor: 11.598

2.  Regulation of protein levels in subcellular domains through mRNA transport and localized translation.

Authors:  Dianna E Willis; Jeffery L Twiss
Journal:  Mol Cell Proteomics       Date:  2010-02-18       Impact factor: 5.911

3.  Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.

Authors:  Huang Huang; Sipei Nie; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao
Journal:  Age (Dordr)       Date:  2016-07-21

Review 4.  Subcellular communication through RNA transport and localized protein synthesis.

Authors:  Christopher J Donnelly; Mike Fainzilber; Jeffery L Twiss
Journal:  Traffic       Date:  2010-10-07       Impact factor: 6.215

Review 5.  Expanding Axonal Transcriptome Brings New Functions for Axonally Synthesized Proteins in Health and Disease.

Authors:  Amar N Kar; Seung Joon Lee; Jeffery L Twiss
Journal:  Neuroscientist       Date:  2017-06-08       Impact factor: 7.519

6.  Requirement of Neuronal Ribosome Synthesis for Growth and Maintenance of the Dendritic Tree.

Authors:  Lukasz P Slomnicki; Maciej Pietrzak; Aruna Vashishta; James Jones; Nicholas Lynch; Shane Elliot; Eric Poulos; David Malicote; Bridgit E Morris; Justin Hallgren; Michal Hetman
Journal:  J Biol Chem       Date:  2016-01-12       Impact factor: 5.157

7.  Transcriptomic Analysis of Ribosome-Bound mRNA in Cortical Neurites In Vivo.

Authors:  Rebecca Ouwenga; Allison M Lake; David O'Brien; Amit Mogha; Adish Dani; Joseph D Dougherty
Journal:  J Neurosci       Date:  2017-08-08       Impact factor: 6.167

8.  Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.

Authors:  Leora M Fox; Christopher M William; David H Adamowicz; Rose Pitstick; George A Carlson; Tara L Spires-Jones; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2011-07       Impact factor: 3.685

9.  Monitoring protein aggregation and toxicity in Alzheimer's disease mouse models using in vivo imaging.

Authors:  Tara L Spires-Jones; Alix de Calignon; Melanie Meyer-Luehmann; Brian J Bacskai; Bradley T Hyman
Journal:  Methods       Date:  2010-12-14       Impact factor: 3.608

10.  Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.

Authors:  Davide Tampellini; Gunnar K Gouras
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.